Showing 2 of 2 recruiting trials for “x-linked-intellectual-disability-acromegaly-hyperactivity-syndrome”
A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)
RecruitingNCT06566066 ↗
Register for Patients With Thyroid Hormone Resistance.
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →